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Three-Phase Model Harmonizes Estimates of the Maximal Suppression of
Parathyroid Hormone by 25-Hydroxyvitamin D in Persons 65 Years of
Age and Older
Abstract
The concentration or threshold of 25-hydroxyvitamin D [25(OH)D] needed to maximally suppress intact
serum parathyroid hormone (iPTH) has been suggested as a measure of optimal vitamin D status. Depending
upon the definition of maximal suppression of iPTH and the 2-phase regression approach used, 2 distinct
clusters for a single 25(OH)D threshold have been reported: 16-20 ng/mL (40-50 nmol/L) and 30-32 ng/
mL (75-80 nmol/L). To rationalize the apparently disparate published results, we compared thresholds from
several regression models including a 3-phase one to estimate simultaneously 2 thresholds before and after
adjusting for possible confounding for age, BMI, glomerular filtration rate, dietary calcium, and season (April-
September vs. October-March) within a single data set, i.e. data from the Tufts University Sites Testing
Osteoporosis Prevention/Intervention Treatment study, consisting of 181 men and 206 women (total n =
387) ages 65-87 y. Plasma 25(OH)D and serum iPTH concentrations were (mean Â± SD) 22.1 Â± 7.44 ng/
mL (55.25 Â± 18.6 nmol/L) and 36.6 Â± 16.03 pg/mL (3.88 Â± 1.7 pmol/L), respectively. The 3-phase
model identified 2 thresholds of 12 ng/mL (30 nmol/L) and 28 ng/mL (70 nmol/L); similar results were
found from the 2-phase models evaluated, i.e. 13-20 and 27-30 ng/mL (32.5-50 and 67.5-75 nmol/L) and
with previous results. Adjusting for confounding did not change the results substantially. Accordingly, the
3-phase model appears to be superior to the 2-phase approach, because it simultaneously estimates the 2
threshold clusters found from the 2-phase approaches along with estimating confidence limits. If replicated, it
may be of both clinical and public health importance.
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Abstract
The concentration or threshold of 25-hydroxyvitamin D [25(OH)D] needed to maximally suppress intact serum parathyroid
hormone (iPTH) has been suggested as a measure of optimal vitamin D status. Depending upon the definition of maximal
suppression of iPTH and the 2-phase regression approach used, 2 distinct clusters for a single 25(OH)D threshold have
been reported: 16–20 ng/mL (40–50 nmol/L) and 30–32 ng/mL (75–80 nmol/L). To rationalize the apparently disparate
published results, we compared thresholds from several regression models including a 3-phase one to estimate
simultaneously 2 thresholds before and after adjusting for possible confounding for age, BMI, glomerular filtration rate,
dietary calcium, and season (April–September vs. October–March) within a single data set, i.e. data from the Tufts
University Sites Testing Osteoporosis Prevention/Intervention Treatment study, consisting of 181 men and 206 women
(total n = 387) ages 65–87 y. Plasma 25(OH)D and serum iPTH concentrations were (mean 6 SD) 22.1 6 7.44 ng/mL
(55.256 18.6 nmol/L) and 36.66 16.03 pg/mL (3.886 1.7 pmol/L), respectively. The 3-phase model identified 2 thresholds
of 12 ng/mL (30 nmol/L) and 28 ng/mL (70 nmol/L); similar resultswere found from the 2-phasemodels evaluated, i.e. 13–20
and 27–30 ng/mL (32.5–50 and 67.5–75 nmol/L) and with previous results. Adjusting for confounding did not change the
results substantially. Accordingly, the 3-phase model appears to be superior to the 2-phase approach, because it
simultaneously estimates the 2 threshold clusters found from the 2-phase approaches along with estimating confidence
limits. If replicated, it may be of both clinical and public health importance. J. Nutr. 140: 595–599, 2010.
Introduction
The circulating blood concentration of 25-hydroxyvitamin D
[25(OH)D]9 is currently considered to be the best measure of
vitamin D status (1). In the absence of direct dose-response data
between 25(OH)D and health outcomes, some have suggested
using the concentration of 25(OH)D needed to maximally
suppress intact serum parathyroid hormone (iPTH) as a possible
approach for determining optimal vitamin D status, especially in
persons over 60–65 y of age (2–4). For this population, maximal
suppression of parathyroid hormone (PTH) is desired, because
higher concentrations, even within the normal range, lead to
bone resorption and bone loss (4,5).
Many investigators have reported the 25(OH)D concentra-
tion or threshold above which PTH was not further suppressed
using a 2-phase regression approach. However, the threshold
points identified have been strikingly varied, ranging from 10 to
50 ng/mL10 (6–11). Several factors could contribute to different
threshold points, including differences in calcium intake and
other population differences, differences in 25(OH)D or PTH
assays, and/or differences related to the choice of statistical
1 Supported by a grant from the National Institute on Aging, NIH, Bethesda, MD,
grant number AG10353, and by an Office of Dietary Supplements administrative
supplement to NIH grant number 5R37 HL045508-17. The findings and
conclusions in this report are those of the authors and do not necessarily
represent the views of the CDC, the NIH, or the US Department of Health and
Human Services.
2 Author disclosures: R. A. Durazo-Arvizu, B. Dawson-Hughes, C. T. Sempos, E. A.
Yetley, A. C. Looker, G. Cao, S. S. Harris, V. L. Burt, A. L. Carriquiry, and M. F.
Picciano, no conflicts of interest.
3 Supplemental Figure 1 and Supplemental Appendix 1 are available with the
online posting of this paper at jn.nutrition.org.
* To whom correspondence should be addressed. E-mail: semposch@mail.nih.
gov.
9 Abbreviations used: GFR, glomerular filtration rate; LOESS, locally weighted
regression smoothing scatterplot; PTH, parathyroid hormone; iPTH, intact
parathyroid hormone; 25(OH)D, 25-hydroxyvitamin D.
10 Conversion: nmol/L = 2.5 × ng/mL.
0022-3166/08 $8.00 ã 2010 American Society for Nutrition.
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approach used. It is important to differentiate between biolog-
ical and statistical sources of differences, because this may
impact the approach to defining the threshold between 25(OH)D
and PTH concentrations in men and women 60–65 y of age and
older.
Several 2-phase regression approaches have been used to
estimate the points of threshold in the association of 25(OH)D
with PTH (4,5). In addition, a 3-phase approach has also been
suggested (12). To date there has been no systematic evaluation,
to our knowledge, of the impact that the choice of statistical
approach has on the threshold point. The purpose of this
analysis is, within the same data set, to estimate and compare
thresholds estimated from several 2-and 3-phase models that use
different assumptions about the shape of the underlying curves
and the definition of maximal suppression of iPTH. The larger
goal is to rationalize the apparently disparate threshold points
that have been identified.
Materials and Methods
Study design. This study is a reanalysis of baseline data from the 445
participants enrolled in the National Institutes on Aging STOP/ITor Sites
Testing Osteoporosis Prevention/Intervention Treatment at Tufts Univer-
sity (10). Volunteers 65 y of age and older were recruited and subsequently
enrolled into the study at an approximately even rate of 35 participants/
mo over a 12.5-mo period. Prior to enrollment, it was established that all
of the participants had normal liver and kidney function. The protocol
for the Sites Testing Osteoporosis Prevention/Intervention Treatment
Study was approved by the Human Investigation Review Committee at
Tufts University and all volunteers gave written informed consent.
Measurements. Medical history including prescription medicine usage
was assessed using questionnaires. Dietary intake was assessed using a
quantitative FFQ that included the use of food models to assess portion
sizes. BMI was calculated as the ratio of measured weight in kilograms
divided by measured height in squared meters.
Blood was drawn by venipuncture after an 8-h fast. Plasma samples
were used to determine 25(OH)D concentrations using the method of
Preece et al. (13). Subsequently, the 25(OH)D values were calibrated to
those of the Diasorin based on a calibration study in which 40 samples
were measured by both methods. Estimated Diasorin values (D) in
ng/mL were calculated from the competitive binding protein values (C)
in ng/mL as D = 5.742+0.538(C). Values of 25(OH)D were converted to
units of nmol/L by multiplying by 2.5. iPTH from serum was measured
with Allegro Intact PTH kits obtained from Nichols Institute. The inter-
assay CV for iPTH was 6.6%. Serum creatinine was measured by
colorimetry with a Cobas Fara centrifugal analyzer (Roche Instruments).
Glomerular filtration rate (GFR) was calculated using the IDMS-
Traceable Modification of Diet in Renal Disease Study equation (14).
The equation is: GFR [mL/(min×1.73 m2)] = 175 × [serum creatinine
(mg/dL)]21.154 × (age)20.203 × (0.742 if female) × (1.210 if Black). Serum
normalized ionized calciumwasmeasured with a Nova 7 analyzer (Nova
Biomedical). All laboratory analyses were performed in the Tufts
Nutrition Evaluation Laboratory in batches as the samples were
collected.
Analytic sample. We excluded 49 participants from the initial sample
of 445 volunteers who reported taking anticonvulsants and thiazide
diuretics. In addition, we excluded 8 participants who reported taking
loop diuretics and 1 individual missing values for 25(OH)D and iPTH.
The final sample size after all the exclusions was 387 and included 181
men and 206 women.
Statistical analysis. The original data set in SPSS was converted to SAS
9 (SAS Institute) and STATA data sets using DBMS/Copy version 7
(Conceptual Software). Subsequent analyses in SAS and STATA 10
showed that there were no errors in the copies made from the original
SPSS data set (data not shown). Means, SD, and Pearson correlation
coefficients were calculated using SAS 9.1. Mean values for men and
women were compared using a t test.
We began our preliminary analyses by fitting a locally weighted
regression smoothing scatterplot (LOESS) line to the data as shown in
Figure 1A (15). The LOESS procedure is a nonparametric method for
fitting a smooth curve that best characterizes the relationship between 2
continuous variables, e.g. iPTH and 25(OH)D (16,17). The curvilinear
shape of the LOESS line supported the fitting of the subsequently
evaluated statistical models (Fig. 1A).
The threshold values for 25(OH)D were calculated for both the
2-phase and 3-phase models using algorithms programmed into STATA
10.0 by one of the authors (R.A.D-A.) (18,19). This threshold point has
been also referred to as the point of inflection, point of intersection,
change-point, or “knot.” The 2-phase model is used to estimate a
threshold that demarcates the point in the PTH-25(OH)D curve above
which PTH is maximally suppressed. The 3-phase model is used to divide
FIGURE 1 (A) Plot of original data with the LOESS model curve
included. (B) Points of intersection or thresholds for the unadjusted
3-phase model compared with the LOESS and the unadjusted
exponential model curves. (C) Comparison of the unadjusted regres-
sion lines from selected 2-phase models with the thresholds from the
unadjusted 3-phase model. A more detailed explanation of the
statistical methods is in Supplemental Appendix 1.
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the curve into 3 parts with 2 thresholds or points of intersection. The
3 phases are: 1) phase 1, where PTH concentrations rapidly decline at a
constant rate with increasing concentrations of 25(OH)D; 2) phase 2
where the rate of decrease in PTH concentrations with increasing
concentrations of 25(OH)D changes to a slower and slower rate; and 3)
phase 3 where PTH is maximally suppressed. The points of intersection
or thresholds between or among phases were estimated using a grid
search approach (18,19). The 95% confidence limits (CL) for the 2-
phase and 3-phase models were calculated from bootstrap estimates
based on 1000 replications (20,21). Bias corrected CL were calculated
with Stata 10 (22,23) and corroborated using the Delta Method (results
not shown). More details are available in Supplemental Appendix 1 and
Supplemental Figure 1.
For the 2-phase model, maximal suppression of iPTH was defined in
2 ways. In the first way, a constraint was imposed that the slope of the
line after the point of intersection must be zero. That is, after the
threshold the change in iPTH per unit change in 25(OH)D was set at
zero. In the other definition, no such constraint or restriction was
imposed and the slope was allowed to be significantly different from
zero.
The single point of inflection for the 2-phase models was estimated
using the following statistical approaches where the constraint was
imposed: piecewise linear, piecewise quadratic-linear, and exponential.
Where the constraint was not imposed, the following statistical
approaches were used: piecewise-linear, piecewise quadratic-linear, and
piecewise quadratic-quadratic. The thresholds for the exponential model
were approximated by calculating the point at which the change (D) in
iPTH per unit change in 25(OH)D was approximately zero. Two values
for DiPTH» 0 were when DiPTHwas 1/100th and 1/300th of the SD for
iPTH, i.e. 0.15 pg/mL and 0.05 pg/mL, respectively. A 3rd approach
using the exponential model to identify a threshold was also explored by
applying the equation by Guillemant et al. (12). More details are
available in Supplemental Appendix 1.
The thresholds were calculated for models unadjusted and adjusted
for possible confounding. The potential confounders considered were:
age, sex, BMI, GFR, ionized calcium, dietary calcium, and season
[summer = April–September and winter = October–March]. In prelim-
inary analyses of a linear model where iPTH was the dependent variable
and 25(OH)D and 25(OH)D2 were forced into the model, we used a
backward elimination procedure to identify the significant confounders
of the relationship between iPTH and 25(OH)D as age, BMI, GFR,
dietary calcium, and season.
Results
The age range for men and women was 65–87 y (Table 1). The
sample was 97% White. Men had somewhat higher 25(OH)D
values. Forty-one percent of the men (74 of 181) and 53% of the
women (109 of 206) had their examinations in the summer (P,
0.05); significantly more men than women had their examina-
tion during the winter months when plasma 25(OH)D concen-
trations are at a low point. This helps to explain why season was
found to be a significant confounder in preliminary analyses. In
addition, men also had a somewhat higher GFR (P , 0.05) and
slightly lower values for ionized serum calcium (P , 0.05).
Results from the various 2-phase approaches indicate that the
estimated thresholds fall into 2 groups or clusters of values
(Table 2). Estimated values tended to be in the 2 clusters of
13–20 ng/mL or 27–30 ng/mL in both unadjusted and adjusted
models. The 1 exception was where the threshold was estimated
to be ~38 ng/mL 25(O)D from the exponential model assuming
a D iPTH of 0.05 pg/mL. The calculated exponential model is:
iPTH ¼ 31:13þ 97:9 × exp½20:151 × 25ðOHÞD;
where 25(OH)D was in units of ng/mL. Using the equation by
Guillemant et al. (10) of 23/C, the estimated threshold of
25(OH)D was 19.9 ng/mL.
Except for the case of the unconstrained piecewise linear or
line-line model, adjusting for confounding had only a relatively
minor effect on the estimates for the point of inflection. In that
case, the unadjusted estimate of the threshold was 13.0 ng/mL
25(OH)D, whereas it was 18.6 ng/mL 25(OH)D after adjusting
for confounding.
Estimated thresholds from the 3-phase model were con-
sistent with the 2 clusters estimated from the 2-phase model
(Table 3). The points of intersection between phases 1 and 2
were 12.4 ng/mL 25(OH)D for the unadjusted approach and
13.2 ng/mL 25(OH)D for the adjusted. Similarly, the point of in-
tersection between phases 2 and 3 was estimated to be 26.0 ng/mL
in the unadjusted model and a slightly higher value of ~29 ng/mL
after adjustment. Moreover, the 3 line segments from the 3-phase
model had a shape that was almost identical to the shape of the
LOESS and exponential model curves (Fig. 1B). Superimposing
the points of intersection or threshold from the 3-phase model
on top of the lines from the 2-phase model revealed that the
threshold from the piecewise linear model corresponded to the
threshold between phases 1 and 2, whereas the threshold for
the piecewise quadratic-linear and exponential models correspond
TABLE 1 Characteristics of the entire sample, men,
and women1
Characteristic Total Men Women
n 387 181 206
Age, y 70.8 6 4.51 70.7 6 4.64 70.8 6 4.41
Plasma 25(OH)D,2 mg/L 22.1 6 7.44 23.7 6 7.62 20.7 6 6.99*
Intact serum PTH, pg/mL 36.6 6 16.03 35.3 6 16.38 37.8 6 15.66
BMI, kg/m2 26.7 6 4.07 26.9 6 3.36 26.5 6 4.60
GFR, mL/(min1.73m2) 76.9 6 14.9 79.2 6 16.13 74.9 6 13.49*
Dietary calcium, mg/d 736 6 352 721 6 374 749 6 331
Serum ionized calcium,3,4 mg/dL 5.04 6 0.15 5.02 6 0.16 5.06 6 0.15*
1 Values are means 6 SD. *Different from men, P , 0.05.
2 To convert to nmol/L, multiply mg/L by 2.5.
3 One man and 1 woman were missing data (n = 385).
4 To convert to mmol/L, multiply mg/dL by 0.25.
TABLE 2 Thresholds of plasma 25(OH)D for the maximal
suppression of iPTH as estimated from the 2-phase
model using selected statistical approaches1
Statistical approach
Point of inflection, ng/mL (95% CL)
Unadjusted Adjusted2
Constraints: D PTH (pg/mL) per 1 ng/mL change in 25(OH)D = 0
Piecewise linear 20.8 (11.6–30.0) 20.8 (11.8–30.0)
Piecewise quadratic-linear 28.0 (13.2–39.8) 29.0 (15.0–39.8)
Exponential3
D= 0.05 37.7 (23.9–73.9) 38.2 (24.2–88.5)
D= 0.15 30.4 (21.1–50.3) 30.5 (21.2–56.9)
Constraints: none
Piecewise linear 13.0 (10.0–28.4) 18.6 (11.2–39.2)
Piecewise quadratic-linear 27.2 (12.6–39.8) 29.0 (12.8–39.8)
Piecewise quadratic-quadratic 27.8 (12.6–39.8) 28.8 (12.8–39.8)
1 To convert to nmol/L, multiply ng/mL by 2.5.
2 Adjusted for age (y), BMI (kg/m2), GFR [mL/(min×1.73m2)], dietary calcium intake
(mg/d), and season (April–September vs. October–March).
3 Model PTH = a + b(exp c[25(OH)D]) with the threshold calculated as the value of
25(OH)D where the difference between successive values of PTH was 0.05 pg/mL
and 0.15 pg/mL, respectively.
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to the threshold between phases 2 and 3 of the 3-phasemodel (Fig.
1C).
The D iPTH per D 25(OH)D for the 3 line segments or phases
of the 3-phase model were for phases 1, 2, and 3: 25.219,
20.796, and 0.00007 pg/mL per ng/mL (22.03, 20.313, and
20.002 pg/mL per nmol/L), respectively. The largest rate of
decline in iPTH per unit decrease in 25(OH)D occurred during
phase 1. The rate of decline in phase 2 was only ~17% of the rate
of decline during phase 1. In phase 3, no further declines in iPTH
occurred with increasing concentrations of 25(OH)D.
Discussion
Within the broad range of 25(OH)D concentrations evaluated in
this data set, the 3-phase model identified 2 threshold points, 1 at
~12 ng/mL and 1 at ~28 ng/mL. Although 2-phase models used
previously, by definition, identified only 1 threshold point, the
points identified have been strikingly close to either the lower or
the higher of these 2 points (12 or 28 mg/L). These findings
suggest that the statistical approach used accounts for a
substantial proportion of the variability in the threshold points
identified to date. As a result, we recommend use of the 3-phase
approach, because it provides a more detailed description of the
association of 25(OH)D with PTH. This approach should be
useful in placing a new threshold into context within the
literature with respect to whether it is the threshold point for the
more rapid or the slower change in PTH. It is important to note
that this study does not rule out the possibility that biological
and environmental factors also affect the threshold point.
Several authors have questioned the use of iPTH to estimate
optimal concentrations of 25(OH)D (4,5,17,24) and have
proposed that history of falls, fracture risk, and chronic disease
risk may be more appropriate clinical measures for determining
optimal concentrations of vitamin D. We wholeheartedly agree
about the importance of clinical endpoints in evaluating optimal
25(OH)D concentrations. However, we also think that an
assessment of the maximal suppression of iPTH by 25(OH)D is
a useful component in enhancing our understanding of that
evaluation (25).
All of the linear regression approaches tend to draw a smooth
line through the data. The objective is to develop a linear
modeling approach that provides the advantages of the linear
model but which closely approximates the shape of the LOESS
curve (5,17,22). The lines from the piecewise quadratic-linear
and piecewise quadratic-quadratic approaches closely approx-
imate the shape of the LOESS curve; however, this approach
allows only the estimation of the threshold where iPTH is
maximally suppressed by 25(OH)D (Fig. 1A). The piecewise
linear approach or the line-line approach, using the terminology
of Aloia et al. (5), on the other hand, provides a good fit for only
the first phase where there is a rapid increase in iPTH with
decreasing concentrations of 25(OH)D. As a result, the different
piecewise approaches appear to identify 2 separate thresholds
or 2 clusters of 25(OH)D values located at the 2 points of
intersection. The curve of the 3-phase approach not only
provides an excellent approximation of the LOESS curve but it
can be used also to estimate both thresholds simultaneously and
evaluate the relative strengths or magnitude of the rate of change
between and among those thresholds.
Two distinct clusters for 25(OH)D were also identified by
Aloia et al. (5) and by Dawson-Hughes et al. (4). Based on a
meta-analysis, Aloia et al. (5) reported clusters at 16–20 ng/mL
and 30–32 ng/mL that are very similar to the 2 clusters found in
this paper. In both of these papers, a 2-phase model was used to
estimate the threshold for 25(OH)D. However, because different
definitions for maximal suppression of iPTH were used in these
papers, different conclusions were reached as to the threshold
between iPTH and 25(OH)D. In the paper by Dawson-Hughes
et al. (4), the authors define maximal suppression of iPTH by
25(OH)D as the concentration of 25(OH)Dwhere iPTHwill not
decrease as a result of any further increases in 25(OH)D.
Aloia et al. (5) estimated the 25(OH)D threshold in the
participants of a randomized clinical trial of 208 African
American women 50–75 y of age. All participants had a total
calcium intake of ;1200–1500 mg/d. The women were ran-
domly assigned to receive 20 mg/d (800 IU/d) of oral cholecal-
ciferol or placebo. After 2 y, the cholecalciferol dose was raised
to 50 mg/d (2000 IU/d) for the final study year. Among women
who received 20 mg/d for the first year, iPTH dropped
213.4 pg/mL in those with baseline 25(OH)D ,16.8 mg/L
(42 nmol/L) but only 22.8 pg/mL in those with higher baseline
25(OH)D. Those results led Aloia et al. (5) to suggest that the
threshold at 16.8 mg/L (42 nmol/L) was a better estimate of the
concentration of 25(OH)D at the point of maximal suppression
of iPTH. Interestingly, the results of Aloia et al. in Blacks were
very similar to the present study, which used a sample that was
97% White.
There are several advantages to the approaches we have
used in this study. The 3-phase model represents a systematic
approach to the estimation of multiple change point parameters,
along with assessment of the amount of uncertainty via
estimation of SE and CL. Other models including fractional
polynomials and cubic splines may be potential alternatives to
the 3-phase model. However, these models might be monotonic,
making it difficult to identify thresholds and change points.
Although the 3-phase model approach appears to be an
improvement over the 2-phase model for estimating the thresh-
old for 25(OH)D at the point of maximal suppression of iPTH,
validation of the model will require replication in other data sets.
The impact that different serum 25(OH)D and iPTH assay
methods might have on the estimation of threshold points needs
to be explored. Also, it remains to be seen if the 3-phase model
will be appropriate for other life-stage and racial/ethnic groups.
If replicated in other data sets for this age group, we think that the
approach may be of both clinical and public health importance.
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